MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$946,982
EPS
$0.04
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative costs
661,050
281,161
292,360.5
213,658
Loss from operations
-661,050
-281,161
-292,360.5*
-213,658
Dividends earned on marketable securities held in trust account
1,644,170
1,613,958
1,729,591.5
1,873,780
Unrealized loss on marketable securities held in trust account
-36,138
-
-
-
Total other income, net
1,608,032
1,613,958
1,729,591.5*
1,873,780
Net income
946,982
1,332,797
1,437,231
1,660,122
Basic EPS
0.04
0.06
0.083
0.08
Diluted EPS
0.04
0.06
0.083
0.08
Basic Average Shares
16,850,200
17,250,000
17,250,000
17,250,000
Diluted Average Shares
16,850,200
17,250,000
17,250,000
17,250,000
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Dividends earned on
marketable securities held...
$1,644,170
(-10.86%↓ Y/Y)
Total other income,
net
$1,608,032
(-12.82%↓ Y/Y)
Unrealized loss on
marketable securities held...
-$36,138
Net income
$946,982
(-41.66%↓ Y/Y)
Loss from operations
-$661,050
(-198.95%↓ Y/Y)
General and
administrative costs
$661,050
(198.95%↑ Y/Y)
Buy us a coffee
Translational Development Acquisition Corp. (TDACU)
Translational Development Acquisition Corp. (TDACU)